01 3Gowling Strathy & Henderson
02 1Gowling WLG (Canada) LLP
01 32085037
02 12346868
01 4Fluvastatin Sodium
01 2Capsule
02 2Extended Release Tablet
01 32012-12-10
02 12019-10-12
Patent Expiration Date : 2012-12-10
Date Granted : 2000-11-28
Brand Name : LESCOL
Patent Number : 2085037
Filing Date : 1992-12-10
Strength per Unit : 20mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-12-10
Date Granted : 2000-11-28
Patent Expiration Date : 2012-12-10
Date Granted : 2000-11-28
Brand Name : LESCOL
Patent Number : 2085037
Filing Date : 1992-12-10
Strength per Unit : 40mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-12-10
Date Granted : 2000-11-28
Patent Expiration Date : 2019-10-12
Date Granted : 2008-09-09
Brand Name : LESCOL XL
Patent Number : 2346868
Filing Date : 1999-10-12
Strength per Unit : 80 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-10-12
Date Granted : 2008-09-09
Patent Expiration Date : 2012-12-10
Date Granted : 2000-11-28
Brand Name : LESCOL XL
Patent Number : 2085037
Filing Date : 1992-12-10
Strength per Unit : 80 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-12-10
Date Granted : 2000-11-28
